GMED · trading date Oct 13, 2026 · previous close $76.28 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$2.94B
Net income
$537.87M
Total assets
$5.30B
Total liabilities
$729.51M
Stockholders' equity
$4.57B
Cash & equivalents
$526.16M
Operating income
$479.82M
Operating cash flow
$753.45M
Capital expenditures
$164.68M
Fiscal year 2025, via 10-K filed 2026-02-24.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
16.3%
Net margin
18.3%
Free cash flow
$588.77M
Free cash flow margin
20.0%
Liabilities / assets
13.8%
Equity / assets
86.2%
CapEx / revenue
5.6%
Operating cash flow / net income
1.40×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Audubon, PA 19403
2560 GENERAL ARMISTEAD AVENUE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:52 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.